BMI1 and Miyoshi myopathy: By reverse transcription quantitative real-time PCR (RT-qPCR) we found that PTC-209 treatment did not reduce the expression of BMI-1 at the mRNA levels, but rather led to an increase in BMI-1 transcript levels in most of the MM cell lines tested in this study (Figure 2A).